Reprocell is partnering with Medicines Discovery Catapult to focus on accelerating drug development for U.K. biotech firms.
NCI Director Ned Sharpless taking on the role of acting head of the FDA raises some intriguing possibilities for interagency cooperation.
Microsoft is bringing its coding skills to bear on biotech, with the goal of building a platform for programming the biology of living cells.
Trump’s budget proposals for 2020 are in, seeking a cut for the NIH for the third year in a row but an increase in the FDA’s finances.
Global CRO Worldwide Clinical Trials has inked a partnership deal with digital pathology startup Deep Lens to focus on the field of oncology.
Clinigen is partnering with Eiger BioPharmaceuticals to launch a program targeting a rare genetic disorder that causes premature aging in children.
The collaboration will leverage excipients ReForm developed to enable the subcutaneous and device-assisted delivery of large molecules.
IQVIA has launched a new de-identification platform aimed at real-world genomic research and protecting patient privacy.
Icon acquired MolecularMD, a specialty lab that focuses on a platform for the development and commercialization of precision medicines for oncology.
Clinerion is partnering with electronic health records software company Medsoft to expand its reach in the country of Georgia.
